BISTTRY11:06Live
Rta Laboratuvarları Biyolojik Ürünler İlaç ve Makine Sanayi Ticaret A.Ş.RTALB
Main MarketChemicals, Petroleum, Rubber and Plastics
1.98−0.03 (−1.49%)
- Volume
- TRY 47.9M
- Day range
- 1.94 – 2.15
- Previous close
- 2.01
- Market cap
- TRY 990M
Net Profit
Sales
Quarterly Sales
Equity
EBITDA
Quarterly EBITDA
Total Assets
Total Liabilities
Frequently asked questions
Quarterly, annualised and cumulative sales, EBITDA, net profit, assets, liabilities and equity series for Rta Laboratuvarları Biyolojik Ürünler İlaç ve Makine Sanayi Ticaret A.Ş. (RTALB), derived from KAP financial reports. Amounts are in TRY.
How much profit did RTALB report in its latest statements?
In the latest period (2025/6) RTALB reported a net profit of TRY 140.9M, sales of TRY 70.6M and EBITDA of TRY 3.5M.
What does annualised mean?
Annualised values sum the last four quarters, giving a seasonally neutral twelve-month figure used in ratios such as P/E and EV/EBITDA.